title: Monodispersed DOTA-PEG-conjugated anti-TAG-72 diabody has low kidney uptake and high tumor-to-blood ratios resulting in improved 64Cu PET.
abstract: Diabodies are noncovalent dimers of single-chain antibody fragments that retain the avidity of intact IgG but have more favorable blood clearance than intact IgG. Radiometals offer a wide range of half-lives and emissions for matching imaging and therapy requirements and provide facile labeling of chelate-antibody conjugates. However, because of their high retention and metabolism in the kidney, the use of radiometal-labeled diabodies can be problematic for both imaging and therapy.
  
  
  METHODS
  Having previously shown that (111)In-DOTA-polyethylene glycol (PEG)3400-anti-carcinoembryonic antigen diabody has less than half the kidney uptake and retention of non-PEGylated diabody and that the two have similarly high tumor uptake and retention, we synthesized a similar derivative for an anti-tumor-associated glycoprotein 72 diabody. We also reduced the molecular size of the polydispersed PEG3400 to monodispersed PEG27 and PEG12 (nominal masses of 1,321 and 617, respectively). We performed biodistributions of their DOTA conjugates radiolabeled with (125)I, (111)In, or (64)Cu in tumor-bearing athymic mice.
  
  
  RESULTS
  The addition of PEG3400 to the diabody reduced kidney uptake to a level (approximately 10 percentage injected dose/g) comparable to that obtained with radiometal-labeled intact IgG. The PEG27 and PEG12 diabody conjugates also demonstrated low kidney uptake without reduction of tumor uptake or tumor-to-blood ratios. When radiolabeled with (64)Cu, the DOTA-PEG12 and -PEG27 diabody conjugates gave high-contrast PET images of colon cancer xenografts in athymic mice.
  
  
  CONCLUSIONS
  PEGylated diabodies may be a valuable platform for delivery of radionuclides and other agents to tumors.
authors.affiliation: Department of Immunology, Beckman Research Institute of City of Hope, Duarte, California 91010, USA.
authors.forename: Lin
authors.initials: L
authors.lastname: Li
authors.forename: Fabio
authors.initials: F
authors.lastname: Turatti
authors.forename: Desiree
authors.initials: D
authors.lastname: Crow
authors.forename: James R
authors.initials: JR
authors.lastname: Bading
authors.forename: Anne-Line
authors.initials: AL
authors.lastname: Anderson
authors.forename: Erasmus
authors.initials: E
authors.lastname: Poku
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Yazaki
authors.forename: Lawrence E
authors.initials: LE
authors.lastname: Williams
authors.forename: Debra
authors.initials: D
authors.lastname: Tamvakis
authors.forename: Paul
authors.initials: P
authors.lastname: Sanders
authors.forename: David
authors.initials: D
authors.lastname: Leong
authors.forename: Andrew
authors.initials: A
authors.lastname: Raubitschek
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Hudson
authors.forename: David
authors.initials: D
authors.lastname: Colcher
authors.forename: John E
authors.initials: JE
authors.lastname: Shively
mesh_terms: D000818:Animals; D002850:Chromatography, Gel; D003001:Cloning, Molecular; D003301:Copper Radioisotopes; D007120:Immunochemistry; D007074:Immunoglobulin G / Q000737:chemistry*; D007525:Isoelectric Focusing; D007668:Kidney / Q000378:metabolism*; D013058:Mass Spectrometry; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism*; D010446:Peptide Fragments / Q000737:chemistry* / Q000493:pharmacokinetics*; D011092:Polyethylene Glycols / Q000737:chemistry* / Q000493:pharmacokinetics*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000737:chemistry* / Q000493:pharmacokinetics*; D014018:Tissue Distribution; D014461:Ultracentrifugation
chemical_list: D003301:Copper Radioisotopes; D007074:Immunoglobulin G; D010446:Peptide Fragments; D019275:Radiopharmaceuticals; D011092:Polyethylene Glycols